Literature DB >> 25747172

Purification of monoclonal antibodies from clarified cell culture fluid using Protein A capture continuous countercurrent tangential chromatography.

Amit K Dutta1, Travis Tran2, Boris Napadensky2, Achyuta Teella2, Gary Brookhart3, Philip A Ropp3, Ada W Zhang4, Andrew D Tustian4, Andrew L Zydney5, Oleg Shinkazh6.   

Abstract

Recent studies using simple model systems have demonstrated that continuous countercurrent tangential chromatography (CCTC) has the potential to overcome many of the limitations of conventional Protein A chromatography using packed columns. The objective of this work was to optimize and implement a CCTC system for monoclonal antibody purification from clarified Chinese Hamster Ovary (CHO) cell culture fluid using a commercial Protein A resin. Several improvements were introduced to the previous CCTC system including the use of retentate pumps to maintain stable resin concentrations in the flowing slurry, the elimination of a slurry holding tank to improve productivity, and the introduction of an "after binder" to the binding step to increase antibody recovery. A kinetic binding model was developed to estimate the required residence times in the multi-stage binding step to optimize yield and productivity. Data were obtained by purifying two commercial antibodies from two different manufactures, one with low titer (∼ 0.67 g/L) and one with high titer (∼ 6.9 g/L), demonstrating the versatility of the CCTC system. Host cell protein removal, antibody yields and purities were similar to those obtained with conventional column chromatography; however, the CCTC system showed much higher productivity. These results clearly demonstrate the capabilities of continuous countercurrent tangential chromatography for the commercial purification of monoclonal antibody products.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Chromatography; Continuous; Monoclonal antibody; Protein A

Mesh:

Substances:

Year:  2015        PMID: 25747172      PMCID: PMC4561037          DOI: 10.1016/j.jbiotec.2015.02.026

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  18 in total

1.  Integrated continuous production of recombinant therapeutic proteins.

Authors:  Veena Warikoo; Rahul Godawat; Kevin Brower; Sujit Jain; Daniel Cummings; Elizabeth Simons; Timothy Johnson; Jason Walther; Marcella Yu; Benjamin Wright; Jean McLarty; Kenneth P Karey; Chris Hwang; Weichang Zhou; Frank Riske; Konstantin Konstantinov
Journal:  Biotechnol Bioeng       Date:  2012-08-06       Impact factor: 4.530

2.  Two step capture and purification of IgG2 using multicolumn countercurrent solvent gradient purification (MCSGP).

Authors:  T Müller-Späth; L Aumann; G Ströhlein; H Kornmann; P Valax; L Delegrange; E Charbaut; G Baer; A Lamproye; M Jöhnck; M Schulte; M Morbidelli
Journal:  Biotechnol Bioeng       Date:  2010-12-15       Impact factor: 4.530

Review 3.  Recovery and purification process development for monoclonal antibody production.

Authors:  Hui F Liu; Junfen Ma; Charles Winter; Robert Bayer
Journal:  MAbs       Date:  2010-09-01       Impact factor: 5.857

4.  Countercurrent tangential chromatography for large-scale protein purification.

Authors:  Oleg Shinkazh; Dharmesh Kanani; Morgan Barth; Matthew Long; Daniar Hussain; Andrew L Zydney
Journal:  Biotechnol Bioeng       Date:  2010-11-22       Impact factor: 4.530

5.  Lumped parameter model for prediction of initial breakthrough profiles for the chromatographic capture of antibodies from a complex feedstock.

Authors:  Hanne Bak; Owen R T Thomas; Jens Abildskov
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-08-21       Impact factor: 3.205

Review 6.  Simulated moving bed chromatography for the separation of enantiomers.

Authors:  Arvind Rajendran; Galatea Paredes; Marco Mazzotti
Journal:  J Chromatogr A       Date:  2008-11-01       Impact factor: 4.759

Review 7.  Evolution of anti-CD20 monoclonal antibody therapeutics in oncology.

Authors:  Ezogelin Oflazoglu; Laurent P Audoly
Journal:  MAbs       Date:  2010-01-30       Impact factor: 5.857

8.  Characterization of large-pore polymeric supports for use in perfusion biochromatography.

Authors:  D Whitney; M McCoy; N Gordon; N Afeyan
Journal:  J Chromatogr A       Date:  1998-05-22       Impact factor: 4.759

9.  Periodic counter-current chromatography -- design and operational considerations for integrated and continuous purification of proteins.

Authors:  Rahul Godawat; Kevin Brower; Sujit Jain; Konstantin Konstantinov; Frank Riske; Veena Warikoo
Journal:  Biotechnol J       Date:  2012-11-09       Impact factor: 4.677

Review 10.  Chromatographic analysis of the acidic and basic species of recombinant monoclonal antibodies.

Authors:  Yi Du; Alison Walsh; Robin Ehrick; Wei Xu; Kimberly May; Hongcheng Liu
Journal:  MAbs       Date:  2012-07-23       Impact factor: 5.857

View more
  4 in total

Review 1.  Recent Developments in Bioprocessing of Recombinant Proteins: Expression Hosts and Process Development.

Authors:  Nagesh K Tripathi; Ambuj Shrivastava
Journal:  Front Bioeng Biotechnol       Date:  2019-12-20

2.  Economic Analysis of Batch and Continuous Biopharmaceutical Antibody Production: A Review.

Authors:  Ou Yang; Maen Qadan; Marianthi Ierapetritou
Journal:  J Pharm Innov       Date:  2019-01-25       Impact factor: 2.750

3.  Application of enhanced electronegative multimodal chromatography as the primary capture step for immunoglobulin G purification.

Authors:  Yanli Wang; Quan Chen; Mo Xian; Rui Nian; Fei Xu
Journal:  AMB Express       Date:  2018-06-01       Impact factor: 3.298

Review 4.  Developments and opportunities in continuous biopharmaceutical manufacturing.

Authors:  Ohnmar Khanal; Abraham M Lenhoff
Journal:  MAbs       Date:  2021 Jan-Dec       Impact factor: 5.857

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.